Abo Bibliothek: Guest
Critical Reviews™ in Oncogenesis

Erscheint 4 Ausgaben pro Jahr

ISSN Druckformat: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

The Current Role of Radiotherapy in the Treatment of Invasive Bladder Cancer

Volumen 7, Ausgabe 5-6, 1996, pp. 457-464
DOI: 10.1615/CritRevOncog.v7.i5-6.40
Get accessGet access

ABSTRAKT

Invasive bladder cancer remains a therapeutic challenge. Approximately 50% of patients treated with radical cystectomy die of metastatic disease. External beam radiation therapy when given alone has results inferior to that of surgery, and although it has shown some benefit when given in the preoperative setting, this was not verified by randomized trials. Altered fractionation radiation schemes and combined modality using a cisplatin-based combination chemotherapy with radiation have resulted in up to 60% bladder preservation.

SCHLÜSSELWÖRTER: bladder neoplasm, radiation, invasive
REFERENZIERT VON
  1. Miyake Hideaki, Hara Isao, Fujisaw Masato, Gleave Martin E, Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects, Expert Review of Anticancer Therapy, 5, 6, 2005. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain